Karen Hager
Blue Owl Capital Holdings Lp
Assets Managed
$372.173M
Holdings
75
Last Quarter
2026 - Q1
Filed Date
1mo 6d ago
Growth Rate
14.86%(2Q avg: 7.73%)
Sustained Growth
3 quarters
Portfolio positions
This chart displays the top 10 holdings in Blue Owl Capital Holdings Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 75 positions.
Assets under management
The assets under management (AUM) of Blue Owl Capital Holdings Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 372.173M in assets, with a quarterly growth rate of 14.86% and a 2-quarter average growth rate of 7.73%. The portfolio is managed by Karen Hager, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
AKTS Aktis Oncology Inc
| 15.2% | $56.557M 3.161M shares@ $17.9 avg price | New Position |
LRMR Larimar Therapeutics Inc
| 8.61% | $32.04M 7.12M shares@ $4.51 avg price | Increased 4.35% |
ENGN Engene Holdings Inc
| 8.09% | $30.075M 4.416M shares@ $6.82 avg price | Increased 31.41% |
NCDL Nuveen Churchill Direct Lend
| 7.33% | $27.267M 2.144M shares@ $12.73 avg price | |
CGEM Cullinan Therapeutics Inc
| 7.3% | $27.138M 1.91M shares@ $14.21 avg price | Decreased -18.76% |
OBDC Blue Owl Capital Corp
| 6.08% | $22.618M 2.045M shares@ $11.06 avg price | |
MPLT Maplight Therapeutics Inc
| 5.5% | $20.451M 1.006M shares@ $20.34 avg price | Increased 207.57% |
CMPX Compass Therapeutics Inc
| 4.19% | $15.561M 2.942M shares@ $5.29 avg price | Decreased -15.14% |
CNTX Context Therapeutics Inc
| 3.59% | $13.333M 5.089M shares@ $2.62 avg price | Decreased -31.53% |
HLLY Holley Inc
| 3.5% | $13.007M 4.237M shares@ $3.07 avg price | Increased 2.18% |
1-10 of 75